Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ImpediMed.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
Health & Biotech
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention
Experts
ScoPo’s Powerplays: Health sector trades sideways but M&A plays coloured the week
Experts
ScoPo’s Powerplays: A disappointing week for healthcare investors
Health & Biotech
Impedimed up 13% after SOZO device gets expanded FDA clearance
News
Market highlights and 6 ASX small caps to watch on Thursday
Experts
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
Experts
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
News
Last Orders: ASX finishes firmly in the red led by tech
News
Market highlights and 5 ASX small caps to watch today
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
News